← FDA DRUG APPROVALS

FDA ANDA · ANDA085383

BUTABARBITAL SODIUM

Sponsor: WOCKHARDT

APPLICATION
ANDA085383
TYPE
ANDA
ORIGINAL APPROVAL
1979-02-26
LATEST ACTION
1992-03-06
ROUTE
ORAL
DOSAGE FORM
ELIXIR
MARKETING STATUS
Discontinued

Products

BUTABARBITAL SODIUMDiscontinued
BUTABARBITAL SODIUM 30MG/5ML · ELIXIR · ORAL

Approval history

1992-03-06Labeling · Supplement 20AP
1989-12-06Labeling · Supplement 19AP
1989-10-10Labeling · Supplement 18AP
1987-08-20Manufacturing (CMC) · Supplement 15AP
1987-02-26Manufacturing (CMC) · Supplement 13AP
1987-02-26Manufacturing (CMC) · Supplement 14AP
1983-12-08Manufacturing (CMC) · Supplement 8AP
1982-07-29Manufacturing (CMC) · Supplement 6AP
1979-02-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →